Document is current
Any future updates will be listed below
-
Authors
Yang, Sijie https://orcid.org/0009-0001-9834-4340
Luo, Xiaowei
Luo, Jiejian
Jian, Fanchong https://orcid.org/0000-0001-8703-3507
Cao, Yunlong https://orcid.org/0000-0001-5918-1078
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32222030)
Ministry of Science and Technology of the People's Republic of China (2021D0102)
Peking University (Boya Postdoctoral Fellowship Program)
China Postdoctoral Science Foundation (GZC20250980)
- License Information
-
More Information
Article History
Received: 17 October 2025
Accepted: 29 April 2026
First Online: 27 May 2026
Competing interests
: Y.C. is the inventor of provisional patent applications for anti-SARS-CoV-2 mAbs (China Patent application no. CN202210131235.9). Y.C. is the founder of Singlomics Biopharmaceuticals. The other authors declare no competing interests.
